net dbt
pg continu best-in-class perform rais outlook deliv yet anoth
quarter outsiz organ growth even comp toughen pt sequenti
remain construct rais outlook organ
sale growth still confid pg abil lift categori innov
captur share believ elev expect achiev sever key
category/market trend strong largest market us
china sequenti acceler pg invest allow
substanti oper leverag oper flexibl continu expand
margin year moreov product save still prioriti
typic back-load help growth comp get tougher later quarter
keep bar high deliv
pg start fy strong sale y/i ep beat est
better expect sale margin sale continu balanc volum
mix price growth across geographi
segment gross oper margin expans acceler
y/i resp outlook revis one quarter book net
organ sale expect prior impli growth mid-point
two year stack vs ep expect prior
impli overal pg remain strong categori drive market growth
take share deliv upsid market growth expect reiter buy
magnific spent rais est reiter buy
pg share outperform year continu see upsid pg trade
ep premium average large-cap hpc despit growth well
ahead addit ep growth expect share continu rerat particularli
light potenti rise challeng seen peer addit activ fund mgr remain
underweight rel weight current vs peak year ago
highlight pg top pick head earn result even
higher qualiti expect buy-rat pg remain top pick
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
procter gambl pg one world largest
consum product compani oper five
babi famili
ariel alway tampax downi dawn
 industri bellweth consum
stapl industri owe diversifi product
portfolio multi-billion brand lead global
share posit result challeng
time recent initi around compani
focus portfolio bear fruit
see potenti sustain top-lin beat
rais quarter ahead
separ pack
goe without say last five quarter out-performance cement
pg lead among consum stapl player calendar year reckitt benckis
fall short expect earlier today report volum declin
temper expect less in-lin print unilev procter
abil beat rais even organ growth comp toughen pt made
breakaway lead sector maintain sequenti y/i organ sale growth
rate impress two-year stack reveal compani acceler
organ growth sinc march quarter push increasingli
last fiscal year culmin impress quarter
balanc year expect acceler two-year stack moder
remain elev around recent perform fuel confid
abil achiev organ sale growth full year high end
guidanc revis today histor preced less applic
given last time organ sale growth two-year stack elev trend
move downward importantli crisis/great recess
begin left reli strength recent perform
confid continu product invest encourag oper
leverage-driven margin expans provid continu bottom-lin lift
sale growth manag
chart organ growth two-year stack unchart territori
last level
distanc peer metric well-earn coo/cfo jon moeller call
broad-bas growth across geographi channel categori justifi
today guidanc rais revenu ep right gate shown
tabl revis guidanc strong first quarter
fx sale
 sale
tabl revis guidanc strong first quarter
underlin breadth growth
encouragingli quarter beat seem broad-bas led geograph
largest market y/i organ sale growth us growth china
acceler last quarter compani happi disclos
region grew outlin strength region specif
russia mexico develop european market includ
germani around franc uk combin brazil
pack notabl choppier market encouragingli still everi
oper segment beat bofaml expect y/i growth everi segment except
groom launch skin guard razor enough off-set
categori competit challeng
tabl segment result
revenu segment
valuat still room run
even given upward revis ep best-in-class growth believ pg still
room valuat especi consid trade calendar price-to-earnings
turn ahead large-cap hpc averag cl though notabl
higher beverag food trade respect rel
stapl histor basi pg trade averag
trade sinc end calendar fundament improv
meaning sinc mind justifi command substanti premium
less incom non-controlling interest
line impact
impact net int /other vs bofaml
impact tax rate vs bofaml
impact equity/nonctrl vs bofaml
impact share vs bofaml
good sold report
good sold
sale
sale
good sold report
good sold
sale
sale
sale
depreci amort
ep charg dilut
price object base ep estim slight discount
target large-cap hpc group use slight discount given pg taken
number action turn around result view bear fruit
top-lin momentum resum potenti margin also see benefit
strength sustain inflat eas longer term continu see pg scale
differenti innov portfolio brand strength key advantag
upsid risk price object faster expect sale growth improv
visibl sustain ahead equiti market turn defens
caus pg defens qualiti rel attract downsid risk
price object slow recent sale momentum advers competit respons
name privat label come month pg look institut price increas
return risk-on would make pg defens qualiti less attract
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
